Love is blind, the saying goes, and thanks to a world-first Australian study, we are now a step closer to understanding why.
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co’s LY-3972406?
LY-3972406 is a small molecule commercialized by Eli Lilly and Co, with a leading Phase II program in Plaque Psoriasis (Psoriasis Vulgaris).